News
India’s first biocompatibility & medical device testing lab
The government of India is taking all steps to improve the medical device sector of the country. The Gujarat Food & Drugs Control Administration (FDCA) gets the allocation of 15 Cr to set up first government biocompatibility and medical device testing lab in India. Commissioner of Gujarat FDCA, Dr Koshia said:
Med Tech Manufacturers forced to consider ISO 13485 Standards
ISO 13485 defines a medical device as any instrument, apparatus, implement, machine, appliance, implant, in vitro reagent or calibrator, software, material, or other similar or related article that is intended by the manufacturer to be used alone or in combination. Registration with ISO 13485 requires the manufacturer to implement an
India to be ahead of China in terms of growth rate: IMF
PM Modi is intent on encouraging growth and foreign investments. The growth rate of India is expected to change from 7.2% in 2014 to 7.5% this year and China to face deceleration with growth rate from 7.4 per cent last year to 6.8% this year and 6.3% a year after.
CDSCO drug inspectors to soon get trained on GMP in line with global counterparts
The Central Drugs Standard Control Organization (CDSCO) has provided drug inspectors training on the relevant areas of current Good Manufacturing Practices (cGMP) in collaboration with US FDA officials. This is being done with the view of the increased exports from India to the United States which rode 32% to US $4.2
Health ministry reconstitutes Drugs Technical Advisory Board
Dr. Jagdish Prasad, Director General of Health Services has been appointed the chairman of the news formed Drugs Technical Advisory Board (DTAB). The DTAB will be the highest decision-making body under the Union health ministry on technical matters. Other members of the DTAB include: C Hariharan, Director in-charge, Central Drugs
India to top Non Vascular Stents Market Growth
Global Data latest report shows that by 2021, India will lead the APAC countries with its market value increasing from $31.5 million in 2013 to $50.4 million, representing a higher CAGR of 6%. Next to follow is Japan and China with CAGRs of 5.2% and 5% respectively. The CDSCO has
“Come Make in India” – Stunning First Visit PM Modi in the US
This article narrates PM Modi’s visit to US stressing Make in India campaign and what it means to the Life Science Sector. FDI & IP: Key Takeaways for the Life Science Industry following the Indian PM Narendra Modi’s first visit to the US Considered to be one of the most